Appealing to CBD Consumers’ Interests in the Cannabinoid
May 31, 2020U.S. Federal Cannabis Legalization Could Be Worth $128.8 Billion in Taxes and 1.6 Million Jobs
June 2, 2020Appealing to CBD Consumers’ Interests in the Cannabinoid
May 31, 2020U.S. Federal Cannabis Legalization Could Be Worth $128.8 Billion in Taxes and 1.6 Million Jobs
June 2, 2020
September 04, 2019
WASHINGTON–(BUSINESS WIRE)– New Frontier Data, the global authority in data, analytics and business intelligence for the cannabis industry, announced today the appointment of Dr. Reggie Gaudino as chief science advisor. In his new role, Dr. Gaudino will advise, guide and participate in internal and external discussions pertinent to the science and medicine of cannabis, strengthening New Frontier Data’s scientific perspective and thought leadership in what is becoming a global medicinal cannabis market.
“Dr. Gaudino is one of the most prominent science-based thought leaders in the cannabis industry,” said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. “He is an internationally recognized scientific voice in cannabis, and his expertise will raise the already-high bar of New Frontier Data’s rigorous research and analytics offerings.”
Dr. Gaudino will continue his scientific research and development efforts, working to better understand and apply cannabis for medical use. Previously, Dr. Gaudino played a vital role in building out the cannabis genetics and research division at Steep Hill, Inc., a cannabis and science technology company. His leadership led to the development of the first commercially offered cannabis DNA-based sex test, and subsequently the first commercially offered cannabis DNA-based CBD test, GenKit™.
Some of Dr. Gaudino’s early achievements include serving as a patent agent with Sequenom to bring valuable insights particularly in cannabis genetics to the industry. Before then, he founded and served as president of Gaudino & Associates, providing intellectual property contract services to clients.
“Elevating the discussion on the need for collection protocols, source vetting, and unbiased and accurate analytics to best understand and predict cannabis markets fluctuations, New Frontier Data has led the way to improved cannabis data reporting standards. I’m thrilled to lend my expertise as they continue to advance market knowledge of this now global industry,” said Dr. Gaudino. “As worldwide interest in cannabis expands, the need for scientific research and understanding follows suit.”
About New Frontier Data:
New Frontier Data is an independent, technology-driven analytics company specializing in the cannabis industry. It offers vetted data, actionable business intelligence and risk management solutions for investors, operators, researchers and policymakers. New Frontier Data’s reports and data have been cited in over 80 countries around the world to inform industry leaders. Founded in 2014, New Frontier Data is headquartered in Washington, D.C. with additional offices in Denver, CO, and London, U.K.
New Frontier Data does not take a position on the merits of cannabis legalization. Rather, its mission and mandate are to inform cannabis-related policy and business decisions through rigorous, issue-neutral and comprehensive analysis of the legal cannabis industry worldwide. For more information about New Frontier Data, please visit: http://www.NewFrontierData.com.
Contacts
Media Contact:
Caroline Kowalski
media@NewFrontierData.com
1-844-420-3882 ext. 3
